Test measuring blood glucose control may help predict risk of CVD events in patients with diabetes
July 25, 2011 in CardiologyMeasuring hemoglobin A 1c (HbA 1c ) levels in patients with diabetes is associated with improvement in models for predicting risk for cardiovascular disease (CVD), according to a report published Online First today by Archives of Internal Medicine.
According to background information in the article, diabetes has been recognized as a risk factor for CVD. But recent research indicates that the level of risk may vary among patients with diabetes. "Simulated cost-benefit analyses have suggested that this variability in CVD risk could provide an opportunity for tailored preventive therapy in diabetic patients," write the authors. They sought to investigate the predictive value of HbA 1c levels; this test reflects the average blood glucose level over the previous two to three months, and generally indicates how well the diabetes is being managed.
Nina P. Paynter, Ph.D., from Brigham and Women's Hospital, Boston, and colleagues, used data from participants of the Women's Health Study and the Physician's Health Study II. To generate the model, they included data from 24,674 women, of whom 685 had diabetes at baseline, and 11,280 men, of whom 563 had diabetes at baseline. Questionnaires provided participants' health history, and baseline blood samples were evaluated for cholesterol, C-reactive protein and HbA 1c levels. The researchers followed up participants for incident (new cases) CVD; women were followed up for a median (midpoint) of 10.2 years and men for a median of 11.8 years.
During follow-up, 125 cardiovascular events occurred in the 685 women with diabetes and 170 events occurred in the 563 men with diabetes (compared with 666 and 1,382 events, respectively, in participants without diabetes). In both sexes, including HbA 1c into risk modeling for CVD improved prediction of CVD compared to classification of all diabetic participants as high risk (10-year risk at least 20 percent). This association was especially pronounced in women. The risk modeling demonstrated that 71.9 percent of female diabetic participants had less than a 20 percent risk of CVD over 10 years, whereas only 24.5 percent of male diabetic participants had a predicted 10-year CVD risk of less than 20 percent. In models that included a term for HbA 1c , there was substantial improvement in CVD risk prediction for women, and more modest improvement in risk prediction for men. Using a yes/no term for diabetes instead of HbA 1c also improved prediction over classification as high risk in both men and women. In women, however, HbA 1c further improved prediction over the yes/no term.
"We found that in these large population-based cohorts of both men and women, presence of diabetes alone did not confer a 10-year risk of CVD higher than 20 percent, and measurement of HbA 1c level in diabetic subjects improved risk prediction compared with classification as cardiovascular risk equivalent," note the researchers. They propose that the difference in risk between the sexes may be partly attributed to the increase in CVD risk with age and the delayed risk in women. The authors call for further research to replicate their results, but conclude, "Our findings suggest that the improvement in CVD risk prediction, and possibly calibration, obtained with adding HbA 1c levels is highest in lower-risk populations."
Commentary: Cardiovascular Risk Stratification, Hemoglobin A 1c , and the Tempo of Translation
An accompanying commentary by Mark J. Pletcher, M.D., M.P.H., from the University of California, San Francisco, notes that the Adult Treatment Panel III (ATP III) guidelines and other cardiovascular disease (CVD) prevention guidelines will be updated soon.
"One specific guideline refinement up for consideration this year is the approach to CVD risk stratification in patients with diabetes," writes Pletcher. He states that under current ATP III guidelines, diabetes is considered a "CHD [coronary heart disease] risk equivalent." Patients with diabetes may be subject to relatively aggressive goals for lowering cholesterol levels, as well as treatment thresholds.
The article by Paynter and colleagues, which includes the HbA 1c level as well as other standard risk factors, appears to improve discrimination and may lead to "more accurate classification of individuals into risk categories," writes Pletcher. The results would be stronger, he adds, if the research had included more patients with diabetes, especially those whose condition was not well controlled; if it had not included revascularizations and strokes, as these were not considered when the current ATP III CHD risk-prediction equation was developed and calibrated; and if the model had included a diabetes indicator variable as well as the HbA 1c measurement.
Pletcher points out that reclassifying some patients with diabetes to lower risk levels would disqualify them from statin therapy to reduce cholesterol levels, and considers whether this is beneficial. "It is not enough to know whether discrimination or reclassification improves with the additional measurement; harm from the new measurement/strategy (both direct and indirect) must be considered and weighed against a realistic estimate of the expected health benefits," he writes.
More information: Arch Intern Med. Published July 25, 2011. doi:10.1001/archinternmed.2011.351 and Arch Intern Med. Published July 25, 2011. doi:10.1001/archinternmed.2011.352
Provided by
JAMA and Archives Journals
-
People at 'intermediate risk' of heart disease with elevated hsCRP benefit from statin therapy
Aug 24, 2010 |
not rated yet |
0
-
Whole grain, bran intake associated with lower risk of death in diabetic women
May 10, 2010 |
not rated yet |
0
-
Use of multiple genetic markers not linked with better risk prediction of CVD
Feb 16, 2010 |
not rated yet |
0
-
Millions face undiagnosed heart risk say researchers after mass screening
Sep 02, 2008 |
not rated yet |
0
-
Folic acid, B vitamins not linked to reduced risk of cardiovascular events in high-risk women
May 06, 2008 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
2 hours ago |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (3) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Work done on body moving in a circle
3 hours ago
-
Crest or Trough?
3 hours ago
-
Origin of magnetism
7 hours ago
-
Polarization vector of water molecule
10 hours ago
-
understanding the strain energy function invariant term
13 hours ago
-
a numerical problem...kindly provide d solution
22 hours ago
- More from Physics Forums - Classical Physics
More news stories
New study should end debate over magnesium treatment for preventing poor outcome after haemorrhagic stroke
An international randomised trial and meta-analysis published Online First in The Lancet should put an end to the debate about the use of intravenous magnesium sulphate to prevent poor outcomes after haemorrhagic stroke. The in ...
Cardiology
3 hours ago |
not rated yet |
0
Low vitamin D in diet increases stroke risk in Japanese-Americans
Japanese-American men who did not eat foods rich in vitamin D had a higher risk of stroke later in life, according to results of a 34-year study reported in Stroke, an American Heart Association journal.
Cardiology
18 hours ago |
not rated yet |
0
Clot buster seems to help up to 6 hours after stroke
(HealthDay) -- The largest study of its kind finds that stroke patients benefit from a clot-busting drug even six hours after a stroke, suggesting that the current recommended 4.5-hour limit could be expanded.
Cardiology
May 24, 2012 |
not rated yet |
0
Calcium supplements linked to significantly increased heart attack risk
Calcium supplements might increase the risk of having a heart attack, and should be "taken with caution," concludes research published in the online issue of the journal Heart.
Cardiology
May 23, 2012 |
not rated yet |
2
|
New study confirms value of cardiac output monitor
(Medical Xpress) -- A new Australian study has confirmed the accuracy of a modern non-invasive cardiac output monitor that can replace a 40-year-old standard in this field.
Cardiology
May 23, 2012 |
not rated yet |
0
Physicians definitively links irritable bowel syndrome and bacteria in gut
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this "gold ...
First study to suggest that the immune system may protect against Alzheimer's changes in humans
Recent work in mice suggested that the immune system is involved in removing beta-amyloid, the main Alzheimer's-causing substance in the brain. Researchers have now shown for the first time that this may apply in humans.
Phone contact with nurses linked with better outcomes for women with gestational diabetes
Among women with gestational diabetes mellitus, referral to a telephone-based nurse management program was associated with lower risk of high baby birth weight and increased postpartum glucose testing, according to Kaiser ...
WHO target to cut early chronic illness deaths
The World Health Organization announced on Friday it was set to approve a new target to reduce premature deaths from chronic illnesses such as heart disease by a quarter by 2025.
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Questionable research practices surprisingly common
(Medical Xpress) -- Not all scientific misconduct is flat-out fraud. Much falls into the murkier realm of questionable research practices. A new study finds that in one field, psychology, these practices are surprisingly ...